Brief: Acelrx Pharmaceuticals Announces Publication Of Study Evaluating Anticoagulation Practices For Continuous Renal Replacement Therapy In The United States
12/12/2023 13:31
Dec 12 (Reuters) - AcelRx Pharmaceuticals Inc ACRX.O :
* ACELRX PHARMACEUTICALS ANNOUNCES PUBLICATION OF STUDY
EVALUATING
ANTICOAGULATION PRACTICES FOR CONTINUOUS RENAL REPLACEMENT
THERAPY IN THE UNITED STATES
Source text for Eikon: ID:nPn29fYNca
Further company coverage: ACRX.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Talphera
See all newsTalphera Inc reports results for the quarter ended June 30 - Earnings Summary
Talphera Inc expected to post a loss of 7 cents a share - Earnings Preview
Talphera Q1 net loss narrows as costs rise on higher development spending
Talphera Q4 net loss widens as operating expenses rise
Brief: Talphera Announces 50% Enrollment Milestone In Ongoing Nephro-Crrt Registrational Trial